Head and neck squamous cell carcinoma with femoral metastasis: a case report and systematic review of current literature
-
By
-
Hannah Chahal
-
Joseph Latham
-
Finlay Ajayi
-
Sasan Dehbozorgi
-
Andrew Miller
-
Gordon Gillespie
-
July 6, 2026
-
Clinical Scorecard: Femoral Metastasis in Head and Neck Squamous Cell Carcinoma: A Case Study and Comprehensive Literature Review
At a Glance
| Category | Detail |
|---|
| Condition | Head and Neck Squamous Cell Carcinoma (HNSCC) |
| Key Mechanisms | Predominantly locoregional spread with rare distant metastases, including femoral involvement. |
| Target Population | Patients with advanced HNSCC, particularly those with tongue squamous cell carcinoma. |
| Care Setting | Oncology and palliative care settings. |
Key Highlights
- Femoral metastasis from HNSCC is exceptionally rare, with only six documented cases.
- Mean age at diagnosis of femoral metastasis is 57 years, with a male predominance.
- Smoking is the most frequently reported risk factor for HNSCC.
- Management is primarily palliative, including radiotherapy and chemoradiotherapy.
- Overall prognosis for patients with femoral metastasis is poor, reflecting aggressive tumor biology.
Guideline-Based Recommendations
Diagnosis
- Histological confirmation of HNSCC is essential for diagnosis.
Management
- Palliative care strategies should be employed, including radiotherapy and orthopaedic stabilization.
Monitoring & Follow-up
- Regular imaging and clinical assessments are necessary to monitor for disease progression.
Risks
- Patients with HNSCC have an increased risk of distant metastases and second primary malignancies.
Patient & Prescribing Data
Patients with advanced-stage HNSCC and evidence of femoral metastasis.
Palliative systemic therapy may provide temporary disease stability.
Clinical Best Practices
- Early recognition of femoral metastasis is crucial for timely palliative intervention.
- Multimodal treatment approaches should be considered for advanced HNSCC.
Related Resources & Content
